Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 26.84
- Piotroski Score 4.00
- Grade Buy
- Symbol (DYN)
- Company Dyne Therapeutics, Inc.
- Price $29.56
- Changes Percentage (-0.57%)
- Change -$0.17
- Day Low $29.18
- Day High $30.00
- Year High $47.45
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/27/2025
- Fiscal Year End N/A
- Average Stock Price Target $45.00
- High Stock Price Target $55.00
- Low Stock Price Target $18.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.98
- Trailing P/E Ratio -7.77
- Forward P/E Ratio -7.77
- P/E Growth -7.77
- Net Income $-235,937,000
Income Statement
Quarterly
Annual
Latest News of DYN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
How 'dynamic' duo of Olivia Miles and Hannah Hidalgo turned Notre Dame into 'Point Guard U'
Notre Dame's point guards Olivia Miles and Hannah Hidalgo are a dynamic duo, showcasing exceptional skills on both ends of the court. Coached by legendary point guard Ivey, they lead the team with the...
By The New York Times | 5 hours ago -
Why Nvidia's championship season has all the makings of an AI dynasty
In 1995-'96, I got to see Michael Jordan play during a rare Chicago Bulls game. Just like the legendary team, Nvidia NVDA is in high demand, akin to the Bulls' popularity during Jordan's era, constant...
By MarketWatch | 2 days ago -
'Happy hour in reverse': where dynamic pricing may creep further
Experts predict surge pricing, seen in industries like transportation and entertainment, could expand to other sectors. This model adjusts prices based on demand, which can lead to higher charges duri...
By The Guardian | 4 days ago
